Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Aug;85(8):1025-9.
doi: 10.1016/j.resuscitation.2014.04.020. Epub 2014 Apr 30.

Combining NSE and S100B with clinical examination findings to predict survival after resuscitation from cardiac arrest

Luis M Calderon  1 , Francis X Guyette  2 , Ankur A Doshi  2 , Clifton W Callaway  2 , Jon C Rittenberger  3 ; Post Cardiac Arrest Service
Collaborators, Affiliations

Combining NSE and S100B with clinical examination findings to predict survival after resuscitation from cardiac arrest

Luis M Calderon et al. Resuscitation. 2014 Aug.

Abstract

Background: Neuron specific enolase (NSE) and astroglial protein S100B are associated with outcome following resuscitation from cardiac arrest. We tested whether NSE and S100B levels are associated with illness severity on hospital arrival, and whether levels are independently associated with survival to hospital discharge after adjusting for initial illness severity.

Methods: Levels of NSE and S100B were obtained at arrival, 6, 12, 24, 48, and 72h after successful resuscitation from cardiac arrest. Clinical data included demographics, Pittsburgh Cardiac Arrest Category (PCAC I-IV) and survival to hospital discharge. Univariable and multivariable predictive models including NSE and S-100B were created to predict survival. ROC analyses were performed to determine sensitivity and specificity of NSE and S-100B at each time interval.

Results: Of 77 comatose subjects, 5 did not receive therapeutic hypothermia and were excluded. Mean age was 59 (SD 16) years, with 58% male (N=42), 72% out-of-hospital arrest (N=52), and 43% VF/VT. Survival was 36% (N=26). PCAC IV was associated with higher levels of NSE at 24h (p=0.001) and S100B at 24h (p=0.005). In the multivariate analysis, survival was associated with initial S100B level (OR 0.24; 95% CI 0.07-0.86). NSE values>49.5ng/mL at 48h and NSE values>10.59ng/mL at 72h predicted mortality. S100B levels>0.414ng/mL at 72h predicted mortality.

Conclusions: More severe neurologic injury on initial examination is associated with higher levels of NSE and S100B. Elevated levels of S100B immediately following resuscitation were associated with death. Persistently elevated levels of NSE and S100B at 48 and 72h were associated with death.

Keywords: Biomarkers; Cardiac arrest; Hypothermia; Outcome; Prognostication.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

The authors have no conflict of interest to report.

Figures

Figure 1
Figure 1
Serum NSE stratified by PCAC. Values are means. Number of subjects at each time point is delineated below the time point. (*different from PCAC II and PCAC III, p<0.05).
Figure 2
Figure 2
a. Serum NSE level by PCAC in subjects who died. Values are means. Number of subjects at each time point is delineated below the time point. b. Serum NSE level by PCAC in subjects who survived. Values are means. Number of subjects at each time point is delineated below the time point.
Figure 2
Figure 2
a. Serum NSE level by PCAC in subjects who died. Values are means. Number of subjects at each time point is delineated below the time point. b. Serum NSE level by PCAC in subjects who survived. Values are means. Number of subjects at each time point is delineated below the time point.
Figure 3
Figure 3
Serum S100B level stratified by PCAC. Values are means. (*different from PCAC II and PCAC III, p<0.05). Number of subjects at each time point is delineated below the time point.
Figure 4
Figure 4
a. Serum S100B level by PCAC in subjects who died. Values are means. Number of subjects at each time point is delineated below the time point. b. Serum S100B level by PCAC in subjects who survived. Values are means. Number of subjects at each time point is delineated below the time point.
Figure 4
Figure 4
a. Serum S100B level by PCAC in subjects who died. Values are means. Number of subjects at each time point is delineated below the time point. b. Serum S100B level by PCAC in subjects who survived. Values are means. Number of subjects at each time point is delineated below the time point.
See this image and copyright information in PMC

References

    1. Nichol G, Thomas E, Callaway CW, et al. Regional variation in out-of-hospital cardiac arrest incidence and outcome. JAMA. 2008;300:1423–1431. - PMC - PubMed
    1. Nolan JP, Soar J. Postresuscitation care: entering a new era. Current Opinion in Critical Care. 16(3):216–222. - PubMed
    1. Neumar RW, et al. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; the Stroke Council. Circulation. 118(23):2452–2483. - PubMed
    1. Laver S, et al. Mode of death after admission to an intensive care unit following cardiac arrest. Intensive Care Medicine. 30(11):2126–2128. - PubMed
    1. Rittenberger JC, et al. An early, novel illness severity score to predict outcome after cardiac arrest. Resuscitation. 2011;82(11):1399–1404. - PMC - PubMed

MeSH terms

Substances